David Canon
About David Canon
David Canon is a Senior Biologics Process Associate at Bristol-Myers Squibb with over a decade of experience in biologics process development. He has a background in environmental science and has worked in both state-level environmental protection and corporate biologics processes.
Company
David Canon is currently employed at Bristol-Myers Squibb as a Senior Biologics Process Associate. He has been with the company for more than 12 years, contributing significantly to its biologics process development initiatives. Bristol-Myers Squibb, based in Devens, MA, is known for its focus on innovative medicines addressing serious and complex diseases.
Title
Holding the title of Senior Biologics Process Associate, David Canon plays a critical role in developing biologics processes at Bristol-Myers Squibb. This position involves working on the production and refinement of biopharmaceuticals, which are essential for creating treatments for various medical conditions.
Education and Expertise
David Canon has a strong educational background in environmental science. He earned a Bachelor of Science degree in Environmental Science: Natural Resources from Paul Smith's College between 2006 and 2008. Prior to that, he completed an Associate of Science in Environmental Science at Greenfield Community College from 2004 to 2006. His educational qualifications have laid a solid foundation for his extensive work in both environmental sciences and biologics process development.
Career Background
David Canon started his career in the field of environmental science. He worked as a Biomonitoring Aide with the New Hampshire Department of Environmental Services in 2010 for six months. Before that, he served as an Engineering Aide at the Massachusetts Department of Environmental Protection for 11 months in 2009. These early roles focused on environmental protection and biomonitoring projects at the state level.
Transition to Biologics
After gaining valuable experience in environmental science, David Canon transitioned to the field of biologics. Over the past decade, he has accumulated extensive experience in biologics process development. At Bristol-Myers Squibb, he has leveraged his background in environmental science to contribute to the development and refinement of biologic medical products.